A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Tocilizumab
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Tocilizumab Versus Baricitinib in Patients With Severe COVID-19
- Status
- COMPLETED
- Phase
- NA
A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Effectiveness Study of Tocilizumab in Patients With Severe COVID-19
- Status
- UNKNOWN
- Phase
- N/A
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Evaluating Tocilizumab for Sever COVID-19 Infection in Breast Cancer vs. Non Cancer Pateints
- Status
- COMPLETED
- Phase
- PHASE2
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
- Status
- RECRUITING
- Phase
- PHASE3
Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients.
- Status
- UNKNOWN
- Phase
- PHASE4
A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
- Status
- UNKNOWN
- Phase
- PHASE4
Comparison of Tocilizumab Versus Tocilizumab/Infliximab in Patients With COVID-19-associated Cytokine Storm Syndrome
- Status
- COMPLETED
- Phase
- N/A
TOCILIZUMAB - An Option for Patients With COVID-19 Associated Cytokine Release Syndrome; A Single Center Experience
- Status
- COMPLETED
- Phase
- PHASE4
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2